{"id":"W2888359685","doi":"10.1158/1078-0432.ccr-18-0110","title":"Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Brain Institute","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Temozolomide; Internal medicine; Rash; Adverse effect; Discontinuation; Phases of clinical research; Radiation therapy; Surgery; Oncology; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001684665,0.0012486,0.002227691,0.0003513865,0.000367268,0.0008188164,0.0008047865,0.0007659824,0.001652959],"category_scores_gemma":[0.001113204,0.0006196502,0.001085264,0.0004665818,0.0006496719,0.000677838,0.000413458,0.002299293,0.0004419905],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001061103,"about_ca_system_score_gemma":0.002102954,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001110377,"about_ca_topic_score_gemma":0.002598815,"domain_scores_codex":[0.9994236,0.0003022179,0.00004657814,0.00009604782,0.00004898055,0.0000825661],"domain_scores_gemma":[0.9989656,0.0001165143,0.0002633319,0.00009370013,0.00008155923,0.0004793283],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8046571,0.07414053,0.02169008,0.0006724651,0.001665309,0.0002564296,0.0002555978,0.001774334,0.02450911,0.0001137251,0.00162485,0.0686406],"study_design_scores_gemma":[0.4867188,0.4811414,0.02550315,0.00003457348,0.0006730529,0.0003231538,0.00007135569,0.001339876,0.002719472,0.0001067376,0.001338756,0.0000295853],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963312,0.001087508,0.0003124956,0.0001356634,0.00006402432,0.001367929,0.0002546138,0.00002668974,0.0004200362],"genre_scores_gemma":[0.995187,0.0008496667,0.0008183693,0.0003015067,0.0001105643,0.001409656,0.0008139677,0.000009533392,0.0004998449],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002227691,"threshold_uncertainty_score":0.008909464,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1639236372288358,"score_gpt":0.5337312416333149,"score_spread":0.3698076044044791,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}